<DOC>
	<DOC>NCT00135070</DOC>
	<brief_summary>Hyperglycaemia has been shown to increase morbidity and mortality in patients with critical illness, myocardial infarction and stroke. This study aims to look at patients with hyperglycaemia and reduce their blood sugar levels using differing combinations of subcutaneous and intravenous insulin.</brief_summary>
	<brief_title>Hospital In-Patient Insulin Study</brief_title>
	<detailed_description>This is a randomised trial involving patients with type II diabetes who are brought into the hospital with a problem other than a diabetic emergency. Patients will be included, who have a blood sugar &gt; than 17mmols. They will be randomised to one of two groups and either given intravenous or subcutaneous insulin. Outcome measures are length of stay, glucose control and comparison of the two regimens. Cost implications will also be analysed.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type II diabetes Blood glucose &gt; 17mmols Type I diabetes Hyperosmolar nonketotic coma (HONK) Diabetic ketoacidosis (DKA) Myocardial infarction (MI) Vomiting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Diabetes Mellitus</keyword>
</DOC>